IBDEI0VA ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15469,1,3,0)
 ;;=3^250.00
 ;;^UTILITY(U,$J,358.3,15469,1,4,0)
 ;;=4^DM II W/O COMP UNSPEC
 ;;^UTILITY(U,$J,358.3,15469,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,15470,0)
 ;;=250.01^^95^942^6
 ;;^UTILITY(U,$J,358.3,15470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15470,1,3,0)
 ;;=3^250.01
 ;;^UTILITY(U,$J,358.3,15470,1,4,0)
 ;;=4^DM I W/O COMP UNSPEC
 ;;^UTILITY(U,$J,358.3,15470,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,15471,0)
 ;;=250.02^^95^942^11
 ;;^UTILITY(U,$J,358.3,15471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15471,1,3,0)
 ;;=3^250.02
 ;;^UTILITY(U,$J,358.3,15471,1,4,0)
 ;;=4^DM II W/O COMP UNCNTRLD
 ;;^UTILITY(U,$J,358.3,15471,2)
 ;;=^331781
 ;;^UTILITY(U,$J,358.3,15472,0)
 ;;=250.03^^95^942^5
 ;;^UTILITY(U,$J,358.3,15472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15472,1,3,0)
 ;;=3^250.03
 ;;^UTILITY(U,$J,358.3,15472,1,4,0)
 ;;=4^DM I W/O COMP UNCNTRLD
 ;;^UTILITY(U,$J,358.3,15472,2)
 ;;=^331782
 ;;^UTILITY(U,$J,358.3,15473,0)
 ;;=583.81^^95^942^13
 ;;^UTILITY(U,$J,358.3,15473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15473,1,3,0)
 ;;=3^583.81
 ;;^UTILITY(U,$J,358.3,15473,1,4,0)
 ;;=4^NEPHRITIS/NEPHROPATHY IN OTH DIS
 ;;^UTILITY(U,$J,358.3,15473,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,15474,0)
 ;;=357.2^^95^942^15
 ;;^UTILITY(U,$J,358.3,15474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15474,1,3,0)
 ;;=3^357.2
 ;;^UTILITY(U,$J,358.3,15474,1,4,0)
 ;;=4^POLYNEUROPATHY IN DM
 ;;^UTILITY(U,$J,358.3,15474,2)
 ;;=^96321
 ;;^UTILITY(U,$J,358.3,15475,0)
 ;;=581.81^^95^942^14
 ;;^UTILITY(U,$J,358.3,15475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15475,1,3,0)
 ;;=3^581.81
 ;;^UTILITY(U,$J,358.3,15475,1,4,0)
 ;;=4^NEPHROTIC SYN IN OTH DIS
 ;;^UTILITY(U,$J,358.3,15475,2)
 ;;=^270346
 ;;^UTILITY(U,$J,358.3,15476,0)
 ;;=276.2^^95^943^1
 ;;^UTILITY(U,$J,358.3,15476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15476,1,3,0)
 ;;=3^276.2
 ;;^UTILITY(U,$J,358.3,15476,1,4,0)
 ;;=4^ACIDOSIS
 ;;^UTILITY(U,$J,358.3,15476,2)
 ;;=^2070
 ;;^UTILITY(U,$J,358.3,15477,0)
 ;;=276.3^^95^943^2
 ;;^UTILITY(U,$J,358.3,15477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15477,1,3,0)
 ;;=3^276.3
 ;;^UTILITY(U,$J,358.3,15477,1,4,0)
 ;;=4^ALKALOSIS
 ;;^UTILITY(U,$J,358.3,15477,2)
 ;;=^4889
 ;;^UTILITY(U,$J,358.3,15478,0)
 ;;=276.51^^95^943^3
 ;;^UTILITY(U,$J,358.3,15478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15478,1,3,0)
 ;;=3^276.51
 ;;^UTILITY(U,$J,358.3,15478,1,4,0)
 ;;=4^DEHYDRATION
 ;;^UTILITY(U,$J,358.3,15478,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,15479,0)
 ;;=253.5^^95^943^4
 ;;^UTILITY(U,$J,358.3,15479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15479,1,3,0)
 ;;=3^253.5
 ;;^UTILITY(U,$J,358.3,15479,1,4,0)
 ;;=4^DIABETES INSIPIDUS
 ;;^UTILITY(U,$J,358.3,15479,2)
 ;;=^33572
 ;;^UTILITY(U,$J,358.3,15480,0)
 ;;=276.9^^95^943^5
 ;;^UTILITY(U,$J,358.3,15480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15480,1,3,0)
 ;;=3^276.9
 ;;^UTILITY(U,$J,358.3,15480,1,4,0)
 ;;=4^ELECTROLYTE DISORDER NOS
 ;;^UTILITY(U,$J,358.3,15480,2)
 ;;=^267949
 ;;^UTILITY(U,$J,358.3,15481,0)
 ;;=276.69^^95^943^6
 ;;^UTILITY(U,$J,358.3,15481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15481,1,3,0)
 ;;=3^276.69
 ;;^UTILITY(U,$J,358.3,15481,1,4,0)
 ;;=4^FLUID OVERLOAD NEC
 ;;^UTILITY(U,$J,358.3,15481,2)
 ;;=^339607
 ;;^UTILITY(U,$J,358.3,15482,0)
 ;;=275.42^^95^943^7
 ;;^UTILITY(U,$J,358.3,15482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15482,1,3,0)
 ;;=3^275.42
 ;;^UTILITY(U,$J,358.3,15482,1,4,0)
 ;;=4^HYPERCALCEMIA
 ;;^UTILITY(U,$J,358.3,15482,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,15483,0)
 ;;=276.0^^95^943^8
 ;;^UTILITY(U,$J,358.3,15483,1,0)
 ;;=^358.31IA^4^2
